Stockholders' Equity

3 Months Ended

Mar. 29, 2026

Equity [Abstract]

Stockholders' Equity

Stockholders’ Equity

Dividends

During the first quarter of 2026 and 2025, the Company paid dividends per share of $.14 and $.25, respectively.

Repurchases of Common Stock

In January 2023, our Board of Directors authorized a repurchase program for up to $500,000 of our common stock through February 28, 2027, when and if market conditions warrant and to the extent legally permissible (the “January 2023 Authorization”). During the three months ended March 29, 2026, no shares were repurchased under the January 2023 Authorization. As of March 29, 2026, the Company had $35,000 of availability remaining under the January 2023 Authorization.

During the three months ended March 30, 2025, the Company repurchased 8,182 shares under the January 2023 Authorization with an aggregate purchase price of $124,070, of which $1,401 was accrued as of March 30, 2025, and excluding excise tax of $1,214 and commissions of $115.

Accumulated Other Comprehensive Loss

The following table provides a rollforward of accumulated other comprehensive loss, which is entirely comprised of foreign currency translation:

	Three Months Ended
	March 29, 2026		March 30, 2025
Balance at beginning of period	$	(63,968)	$	(74,753)
Foreign currency translation	(2,796)		1,912
Balance at end of period	$	(66,764)	$	(72,841)